Skip to main content
Premium Trial:

Request an Annual Quote

Cognia Licenses ITI Technology to Build Drug-Discovery Database

NEW YORK (GenomeWeb News) – ITI Life Sciences has licensed its data-mining technology to bioinformatics company Cognia to develop a drug-discovery database, the companies said today.
 
Cognia’s European branch, Cognia EU, worked with an ITI research program and with the University of Edinburgh’s School of Informatics to develop the technology, the companies said.
 
Under the agreement, ITI will receive royalties from sales of the resulting product. ITI said these proceeds will be re-invested in the ITI Life Sciences Text Mining research program, a 3-year initiative that is scheduled to end in one year.
 
ITI said it expects to sign more licensing agreements with technology developed under this program.  
 
The companies also said they plan to sign a permanent agreement later this year.
 
Cognia said it can deploy and commercialize the IP immediately, and said it expects to create “numerous databases” from the text-mining program.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.